
Yes. Tingling, pins and needles, and patches of numbness are recognized symptoms of withdrawal from Klonopin (clonazepam). The medical word is paresthesia.
Professor C. Heather Ashton lists tingling, numbness, and altered sensation in the limbs, face, and trunk in the symptom table in Chapter III of the Ashton Manual. The Klonopin label approved by the United States Food and Drug Administration (FDA) names paresthesia among the symptoms of protracted withdrawal.
Patients describe hands and feet that feel asleep, a buzzing lip or cheek, or a numb patch on the trunk that moves from day to day. It is frightening, and the first thought is often a stroke. So, what is happening, and what should be done about the taper?
Benzodiazepines strengthen the effect of gamma-aminobutyric acid (GABA), the brain’s main calming signal, and over months or years the nervous system adapts. When the dose falls, Professor Ashton wrote in Chapter III, the sensory nerves and their connections in the spinal cord and brain become hyperexcitable. In the same chapter, she reported that nerve conduction tests on her own patients found nothing abnormal, and she called these symptoms “usually nothing to worry about.”
It is like a smoke detector set so sensitive that it sounds when someone makes toast. The alarm is real. The fire is not.
That adaptation is physical dependence, and it happens to people who took Klonopin exactly as prescribed. Physical dependence is not addiction. Fortunately, the answer to the tingling is a change to the taper.
Klonopin is potent. The equivalence table in Chapter I of the Ashton Manual rates clonazepam at about twenty times the strength of diazepam (Valium), milligram for milligram. Chapter II adds that a smooth, slow fall in blood concentration is difficult to achieve with it.
So, a reduction that looks tiny on the tablet can be a large step for the nervous system. Tingling that starts in the days after a cut often means the step was too large or came too soon.
The first response is to tell the prescriber and hold the dose until the sensations settle. Chapter II says a person can stay at a difficult point for a few weeks and must be in control of the pace. Dr. Mark Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, treats a hold as protective. It is not a failure.
After the hold, the steps get smaller. The Manual describes reductions of up to one tenth of the dose, and the Maudsley Deprescribing Guidelines describe a hyperbolic pattern, in which reductions get smaller as the dose gets lower. With a drug this potent, that can mean a liquid form or, where it helps, a crossover taper to diazepam.
If a cut proves too large, a small step back up, agreed with the prescriber, is legitimate. The Klonopin label itself allows for a return to the previous dose, followed by a slower taper.
Stopping Klonopin to end the tingling is the wrong answer. The label warns that abrupt discontinuation or rapid dosage reduction can bring on life-threatening withdrawal reactions, including seizures. A Klonopin taper takes months, and sometimes longer.
In most cases, yes, though not in a straight line. Chapter III describes symptoms that wax and wane, with “windows” of feeling well that grow longer and more frequent. Patients call the bad stretches waves, and a wave after weeks of quiet is part of the pattern.
The sensations usually fade over weeks to months. For a minority they linger after the last dose, and the label says protracted symptoms may last from weeks to more than 12 months. Professor Ashton wrote in Chapter III that even when these sensations seem almost permanent, they decline in severity over the years and do not signify a major neurological illness.
Patients often describe relief from simple things: a warm bath, gentle walking or stretching, a change of position, slow breathing. Understanding the symptom helps too, because fear amplifies it.
However, the evidence for these comfort measures is limited, what soothes one person does nothing for another, and none of them replaces a slower taper. Questions about supplements are decided per patient, with a physician who understands the pharmacology.
When it is sudden or one-sided, or when it comes with chest pain. Not every tingle during a taper is withdrawal. Sudden numbness or weakness on one side of the body, a drooping face, or trouble speaking can mean a stroke, and tingling in the arm or jaw with chest pain can mean a heart attack. Call 911 for any of these, for a seizure, or for any other medical emergency.
Numbness that stays in one place, steadily worsens, or comes with loss of strength deserves an ordinary medical evaluation. Diabetes, thyroid problems, and pinched nerves cause tingling too.
Dr. Leeds’ practice offers one service: medically supervised benzodiazepine and z-drug tapering for patients in Florida, at a pace the patient sets. There, a symptom like tingling is information about the pace of the taper. Contact Dr. Leeds to ask about a slow, supervised Klonopin taper.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. He helps patients come off benzodiazepines and sleeping pills with a slow, patient-directed taper guided by the Ashton Manual and the Maudsley Deprescribing Guidelines. Physical dependence is not addiction, and a careful taper is measured in months, not days.
Contact Us for expert guidance on safely tapering off benzodiazepines and reclaiming your life.





